skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)-positive parotid incidentaloma: Prevalence and clinical significance

Original Research

(4709) Views  (1560) Full article downloads

Authors: Urszula Kiendys, Hamphrey Ham, Wouter Bauters, Caroline Van den Broecke, Philippe Deron, Ingeborg Goethals

Published Date January 2009 Volume 2009:2 Pages 1 - 6
DOI: http://dx.doi.org/10.2147/RMI.S4559

Urszula Kiendys1, Hamphrey Ham1, Wouter Bauters2, Caroline Van den Broecke3, Philippe Deron4, Ingeborg Goethals1

1Department of Nuclear Medicine; 2Department of Radiology; 3Department of Pathology; 4Department of Head and Neck Surgery, Ghent University Hospital, Ghent, Belgium

Aim: To evaluate the prevalence of parotid incidentaloma identified by F-18 fluorodeoxyglucose PET(-CT) scan and the clinical significance associated with this finding.

Methods: Records from all patients from January 1, 2005 to August 31, 2007 who had focal intense abnormal F-18 FDG uptake in the parotid glands without a previous history of squamous cell carcinoma in the head and neck, lymph node metastasis from an unknown primary in the head and neck region or lymphoma, were reviewed.

Results: Of the 5476 PET-CT scans performed in as many patients, focal high-grade parotid F-18 FDG uptake was observed in 18 patients (prevalence of 0.3%). Eight patients (44%) underwent surgery. Four of 8 patients (50%) had benign tumors, 2 (25%) had infectious disease and 1 patient each had metastatic disease from a melanoma and a non-Hodgkin’s lymphoma.

Conclusion: F-18 FDG PET-positive parotid incidentaloma is rare. The prevalence of a PETpositive parotid incidentaloma in our study was 0.3%. Clear-cut focal high-grade abnormal F-18 FDG uptake was seen in benign tumors, infectious and metastatic disease.

Keywords: F-18 FDG PET-CT scanning, incidentaloma, parotid gland, prevalence








Readers of this article also read:

Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Potential renovascular hypertension, space missions, and the role of magnesium
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Amino acid-responsive Crohn's disease: a case study
Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University